Impact BioMedical Statistics

Total Valuation

IBO has a market cap or net worth of $71.16 million. The enterprise value is $71.16 million.

Market Cap	71.16M
Enterprise Value	71.16M

Important Dates

The next estimated earnings date is Tuesday, May 12, 2026, after market close.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

IBO has 107.82 million shares outstanding. The number of shares has increased by 193.30% in one year.

Current Share Class	107.82M
Shares Outstanding	107.82M
Shares Change (YoY)	+193.30%
Shares Change (QoQ)	+636.68%
Owned by Insiders (%)	2.83%
Owned by Institutions (%)	1.34%
Float	11.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2,223.81
Forward PS	n/a
PB Ratio	5.48
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2,223.72
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.35

Current Ratio	0.35
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.38

Financial Efficiency

Return on equity (ROE) is -104.16% and return on invested capital (ROIC) is -16.85%.

Return on Equity (ROE)	-104.16%
Return on Assets (ROA)	-14.16%
Return on Invested Capital (ROIC)	-16.85%
Return on Capital Employed (ROCE)	-26.29%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$16,000
Profits Per Employee	-$5.92M
Employee Count	2
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-2.58M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.64% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+52.64%
50-Day Moving Average	0.57
200-Day Moving Average	0.56
Relative Strength Index (RSI)	53.99
Average Volume (20 Days)	122,705

Short Selling Information

The latest short interest is 1.21 million, so 1.12% of the outstanding shares have been sold short.

Short Interest	1.21M
Short Previous Month	1.32M
Short % of Shares Out	1.12%
Short % of Float	10.60%
Short Ratio (days to cover)	2.19

Income Statement

In the last 12 months, IBO had revenue of $32,000 and -$11.84 million in losses. Loss per share was -$0.38.

Revenue	32,000
Gross Profit	-392,000
Operating Income	-4.27M
Pretax Income	-14.45M
Net Income	-11.84M
EBITDA	-3.13M
EBIT	-4.27M
Loss Per Share	-$0.38

Full Income Statement

Balance Sheet

The company has $3,000 in cash and n/a in debt, giving a net cash position of $3,000 or $0.00 per share.

Cash & Cash Equivalents	3,000
Total Debt	n/a
Net Cash	3,000
Net Cash Per Share	$0.00
Equity (Book Value)	15.56M
Book Value Per Share	0.12
Working Capital	-751,000

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.89M
Capital Expenditures	n/a
Depreciation & Amortization	1.15M
Net Borrowing	-109,000
Free Cash Flow	-1.89M
FCF Per Share	-$0.02

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-13,343.75%
Pretax Margin	-45,156.25%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IBO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-193.30%
Shareholder Yield	-193.30%
Earnings Yield	-16.64%
FCF Yield	-2.66%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IBO has an Altman Z-Score of 0.58 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.58
Piotroski F-Score	2